diff --git a/src/contents/Human Practices/IHP.tsx b/src/contents/Human Practices/IHP.tsx
index cd0d4dfaa8720cc7f13149c18498241f9968caa1..0bc69305e88ed2e434d1fa9c16708a14eae1b16b 100644
--- a/src/contents/Human Practices/IHP.tsx	
+++ b/src/contents/Human Practices/IHP.tsx	
@@ -109,6 +109,9 @@ export function HPIntegrated(){
                         </a>
                     </div>
                 </div>
+                <p style={{ textAlign: "center", marginTop: "10px", fontStyle: "italic" }}>
+                    Click on the images above to learn more about each category.
+                </p>
                 {/* TABS */}
                 <div className="mendelowtab" id="mendelow-one" style={{display: "none"}}>
                     <H4 text="Key Players" id="keyplayersH"/>
@@ -270,26 +273,24 @@ export function HPIntegrated(){
                     <tbody>
                         <tr>
                             <td>Strong support network for patients </td>
-                            <td>Influential in policy advocacy </td>
-                            <td>Personal connection to patient communities </td>
-                        </tr>
-                        <tr>
                             <td>Limited funding and resources </td>
-                            <td>Potential resistance to new technologies </td>
-                            <td>Dependence on donations and grants </td>
-                        </tr>
-                        <tr> 
-                            <td>Increased patient engagement and support for new therapies </td>
-                            <td>Advocacy can drive policy changes </td>
-                            <td>Enhancing awareness and education </td>
-                        </tr>
-                        <tr> 
-                            <td>Potential opposition from groups skeptical of new treatments </td>
-                            <td>Misinformation or miscommunication about new therapies </td>
-                            <td>Competing priorities among advocacy groups </td>
-                        </tr>
-                    </tbody>
-                </table>
+                            <td>Increased patient engagement and support for new therapies</td>
+            <td>Potential opposition from groups skeptical of new treatments</td>
+        </tr>
+        <tr>
+            <td>Influential in policy advocacy</td>
+            <td>Potential resistance to new technologies</td>
+            <td>Advocacy can drive policy changes</td>
+            <td>Misinformation or miscommunication about new therapies</td>
+        </tr>
+        <tr>
+            <td>Personal connection to patient communities</td>
+            <td>Dependence on donations and grants</td>
+            <td>Enhancing awareness and education</td>
+            <td>Competing priorities among advocacy groups</td>
+        </tr>
+    </tbody>
+</table>
 
                 </div>
                 <div className="col subcycletab" id="inds" style={{display: "none"}}>